Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.IsomAb secures funds to advance peripheral arterial disease treatment
IsomAb’s ISM-001 is a humanised antibody aimed at restoring blood flow in patients with diabetic vascular disease. Credit: Daniel Roberts from Pixabay.
IsomAb’s ISM-001 is a humanised antibody aimed at restoring blood flow in patients with diabetic vascular disease. Credit: Daniel Roberts from Pixabay.